Xilio Therapeutics, Inc.
NASDAQ:XLO
1.15 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||||||
| Current Assets: | |||||||||||||||||
| Cash & Cash Equivalents
| 61.259 | 74.949 | 33.98 | 44.704 | 59.772 | 75.383 | 93.271 | 120.385 | 139.143 | 159.41 | 176.959 | 198.053 | 99.767 | 120.299 | 141.222 | 19.238 | -48.845 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 97.69 |
| Cash and Short Term Investments
| 61.259 | 74.949 | 33.98 | 44.704 | 59.772 | 75.383 | 93.271 | 120.385 | 139.143 | 159.41 | 176.959 | 198.053 | 99.767 | 120.299 | 141.222 | 19.238 | 48.845 |
| Net Receivables
| 0 | 0 | 30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 2.05 | 3.059 | 5.205 | 3.423 | 4.708 | 3.042 | 7.41 | 8.222 | 6.342 | 7.194 | 8.256 | 8.928 | 5.805 | 4.287 | 1.4 | 1.352 | 0 |
| Total Current Assets
| 63.309 | 78.008 | 69.185 | 48.127 | 64.48 | 78.425 | 93.271 | 124.496 | 142.314 | 163.007 | 181.087 | 202.517 | 105.572 | 124.586 | 142.622 | 20.59 | 48.845 |
| Non-Current Assets: | |||||||||||||||||
| Property, Plant & Equipment, Net
| 9.574 | 10.004 | 10.54 | 11.201 | 11.613 | 12.163 | 12.729 | 12.84 | 13.242 | 13.231 | 13.353 | 13.597 | 13.173 | 13.449 | 13.699 | 13.676 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -5.092 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 1.769 | 2.763 | 1.587 | 1.58 | 1.574 | 1.568 | 1.562 | 1.557 | 1.554 | 1.553 | 1.553 | 1.553 | 1.553 | 1.553 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.539 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 1.775 | 0.092 | 0.121 | 0.011 | 0.169 | 0.197 | 3.937 | 0.267 | 0.301 | 0.335 | 0.359 | -3.146 | 0.427 | 0.436 | 0.47 | 2.051 | -48.845 |
| Total Non-Current Assets
| 11.349 | 11.865 | 13.424 | 12.799 | 13.362 | 13.934 | 18.234 | 14.669 | 15.1 | 15.12 | 15.265 | 15.543 | 15.153 | 15.438 | 15.722 | 15.727 | -48.845 |
| Total Assets
| 74.658 | 89.873 | 82.609 | 60.926 | 77.842 | 92.359 | 111.505 | 139.165 | 157.414 | 178.127 | 196.352 | 218.06 | 120.725 | 140.024 | 158.344 | 36.317 | 0 |
| Liabilities & Equity: | |||||||||||||||||
| Current Liabilities: | |||||||||||||||||
| Account Payables
| 0.972 | 1.264 | 0.746 | 1.05 | 1.486 | 0.945 | 2.013 | 3.125 | 1.81 | 1.41 | 2.324 | 3.144 | 3.822 | 8.409 | 2.608 | 5.444 | 0 |
| Short Term Debt
| 1.152 | 2.232 | 1.081 | 1.047 | 2.028 | 1.962 | 7.616 | 7.585 | 6.776 | 5.049 | 3.325 | 0.801 | 1.546 | 4.746 | 4.052 | 2.897 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 26.105 | 26.517 | 21.725 | 0 | 9.404 | 7.14 | 0 | 0 | 0 | 12.087 | 0 | 8.751 | 8.194 | 8.068 | 0 | 13.732 | 0 |
| Other Current Liabilities
| 9.793 | 8.628 | 8.03 | 13.86 | 13.415 | 13.386 | 6.565 | 10.409 | 8.256 | 11.311 | 6.576 | 8.833 | 7.503 | 8.15 | 9.634 | 13.814 | 0 |
| Total Current Liabilities
| 38.022 | 38.641 | 31.582 | 15.957 | 16.929 | 16.293 | 16.194 | 21.119 | 16.842 | 17.77 | 12.225 | 12.778 | 12.871 | 21.305 | 16.294 | 22.155 | 0 |
| Non-Current Liabilities: | |||||||||||||||||
| Long Term Debt
| 7.263 | 7.566 | 7.863 | 16.284 | 16.83 | 8.682 | 10.493 | 12.354 | 14.21 | 16.058 | 17.906 | 19.735 | 30.212 | 16.003 | 17.171 | 18.32 | 0 |
| Deferred Revenue Non-Current
| 8.399 | 10.25 | 17.399 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -3.539 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | -17.399 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.539 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | -8.142 | -8.415 | 0.007 | 0.026 | 0.045 | 0.064 | 0.082 | 0.1 | 0.118 | 214.097 | 224.025 | 1.126 | 79.129 | 0 |
| Total Non-Current Liabilities
| 15.662 | 17.816 | 25.262 | 8.142 | 8.415 | 8.689 | 10.519 | 12.399 | 14.274 | 16.14 | 18.006 | 19.853 | 244.309 | 240.028 | 18.297 | 97.449 | 0 |
| Total Liabilities
| 53.684 | 56.457 | 56.844 | 24.099 | 25.344 | 24.982 | 26.713 | 33.518 | 31.116 | 33.91 | 30.231 | 32.631 | 257.18 | 261.333 | 34.591 | 119.604 | 0 |
| Equity: | |||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 222.888 | 222.888 | 222.888 | 78.002 | 68.033 |
| Common Stock
| 0.004 | 0.004 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0 | 0.001 | 0.001 | 0 | 0 |
| Retained Earnings
| -370.66 | -356.64 | -342.715 | -325.512 | -307.857 | -291.109 | -271.754 | -249.108 | -226.642 | -206.852 | -182.239 | -160.886 | -141.185 | -124.934 | -101.753 | -85.086 | 0 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | 0 | 0 | -0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -222.889 | -0 | -0 | -29.523 |
| Other Total Stockholders Equity
| 391.63 | 390.052 | 368.477 | 362.336 | 360.352 | 358.483 | 356.543 | 354.752 | 352.937 | 351.066 | 348.357 | 346.312 | 4.73 | -219.263 | 2.617 | -76.203 | 0 |
| Total Shareholders Equity
| 20.974 | 33.416 | 25.765 | 36.827 | 52.498 | 67.377 | 84.792 | 105.647 | 126.298 | 144.217 | 166.121 | 185.429 | -136.455 | -121.309 | 123.753 | -83.287 | 38.51 |
| Total Equity
| 20.974 | 33.416 | 25.765 | 36.827 | 52.498 | 67.377 | 84.792 | 105.647 | 126.298 | 144.217 | 166.121 | 185.429 | -136.455 | -121.309 | 123.753 | -83.287 | 38.51 |
| Total Liabilities & Shareholders Equity
| 74.658 | 89.873 | 82.609 | 60.926 | 77.842 | 92.359 | 111.505 | 139.165 | 157.414 | 178.127 | 196.352 | 218.06 | 120.725 | 140.024 | 158.344 | 36.317 | 38.51 |